肺炎球菌ワクチンの世界市場2020-2026:PPSV 23、PCV 7/13、PCV 10

QYResearchが発行した調査報告書(QYR20AP01868)
◆英語タイトル:Global Pneumococcal Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP01868
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:115
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、肺炎球菌ワクチンの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、肺炎球菌ワクチンのグローバル市場動向、メーカー別競争状況、種類別市場規模(PPSV 23、PCV 7/13、PCV 10)、用途別市場規模(子供、大人)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・肺炎球菌ワクチンの種類別市場2015-2026:PPSV 23、PCV 7/13、PCV 10
・肺炎球菌ワクチンの用途別市場2015-2026:子供、大人
・肺炎球菌ワクチンの北米市場分析
・肺炎球菌ワクチンのアジア市場分析
・肺炎球菌ワクチンの中南米市場分析
・肺炎球菌ワクチンの中東・アフリカ市場分析
・関連企業情報:Pfizer、GSK、MSD、Sanofipasteur、CDIBP
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40% in 2015.
The second place is Europe, following North America with sales market share over 18% in 2016. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share in 2013, but the consumption experienced a sharp decrease due to approval of government departments in last few years.
In 2019, the global Pneumococcal Vaccine market size was US$ 7038.2 million and is forecast to US$ 7605 million in 2026, growing at a CAGR of 1.1% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Pneumococcal Vaccine.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Pneumococcal Vaccine market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Pneumococcal Vaccine market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Pneumococcal Vaccine market. Readers of the report can become informed about current and future trends of the global Pneumococcal Vaccine market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Pneumococcal Vaccine markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Pneumococcal Vaccine market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Pneumococcal Vaccine market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Pneumococcal Vaccine market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Pneumococcal Vaccine market is segmented into
PPSV 23
PCV 7/13
PCV 10

Market Segment by Application, the Pneumococcal Vaccine market is segmented into
Child
Adult

This report includes the following manufacturers; we can also add the other companies as you want.
Pfizer
GSK
MSD
Sanofipasteur
CDIBP

The study objectives are:
To analyze and research the global Pneumococcal Vaccine status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Pneumococcal Vaccine manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Pneumococcal Vaccine are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Pneumococcal Vaccine Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Pneumococcal Vaccine Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 PPSV 23
1.3.3 PCV 7/13
1.3.4 PCV 10
1.4 Market Segment by Application
1.4.1 Global Pneumococcal Vaccine Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Child
1.4.3 Adult
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Pneumococcal Vaccine Revenue (2015-2026)
2.1.1 Global Pneumococcal Vaccine Revenue (2015-2026)
2.1.2 Global Pneumococcal Vaccine Sales (2015-2026)
2.2 Pneumococcal Vaccine Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Pneumococcal Vaccine Sales by Regions (2015-2020)
2.2.2 Global Pneumococcal Vaccine Revenue by Regions (2015-2020)
2.3 Global Top Pneumococcal Vaccine Regions (Countries) Ranking by Market Size
2.4 Pneumococcal Vaccine Industry Trends
2.4.1 Pneumococcal Vaccine Market Top Trends
2.4.2 Market Drivers
2.4.3 Pneumococcal Vaccine Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Pneumococcal Vaccine Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Pneumococcal Vaccine Manufacturers by Sales (2015-2020)
3.1.1 Global Pneumococcal Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Global Pneumococcal Vaccine Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Pneumococcal Vaccine Sales in 2019
3.2 Global Top Manufacturers Pneumococcal Vaccine by Revenue
3.2.1 Global Pneumococcal Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Global Pneumococcal Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pneumococcal Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Vaccine as of 2019)
3.4 Global Pneumococcal Vaccine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Pneumococcal Vaccine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Pneumococcal Vaccine Market
3.7 Key Manufacturers Pneumococcal Vaccine Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Pneumococcal Vaccine Historic Market Review by Type (2015-2020)
4.1.2 Global Pneumococcal Vaccine Sales Market Share by Type (2015-2020)
4.1.3 Global Pneumococcal Vaccine Revenue Market Share by Type (2015-2020)
4.1.4 Pneumococcal Vaccine Price by Type (2015-2020)
4.1 Global Pneumococcal Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Pneumococcal Vaccine Sales Forecast by Type (2021-2026)
4.2.3 Global Pneumococcal Vaccine Revenue Forecast by Type (2021-2026)
4.2.4 Pneumococcal Vaccine Price Forecast by Type (2021-2026)

5 Global Pneumococcal Vaccine Market Size by Application
5.1 Global Pneumococcal Vaccine Historic Market Review by Application (2015-2020)
5.1.2 Global Pneumococcal Vaccine Sales Market Share by Application (2015-2020)
5.1.3 Global Pneumococcal Vaccine Revenue Market Share by Application (2015-2020)
5.1.4 Pneumococcal Vaccine Price by Application (2015-2020)
5.2 Global Pneumococcal Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Pneumococcal Vaccine Sales Forecast by Application (2021-2026)
5.2.3 Global Pneumococcal Vaccine Revenue Forecast by Application (2021-2026)
5.2.4 Pneumococcal Vaccine Price Forecast by Application (2021-2026)

6 North America
6.1 North America Pneumococcal Vaccine Breakdown Data by Company
6.2 North America Pneumococcal Vaccine Breakdown Data by Type
6.3 North America Pneumococcal Vaccine Breakdown Data by Application
6.4 North America Pneumococcal Vaccine Breakdown Data by Countries
6.4.1 North America Pneumococcal Vaccine Sales by Countries
6.4.2 North America Pneumococcal Vaccine Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Pneumococcal Vaccine Breakdown Data by Company
7.2 Europe Pneumococcal Vaccine Breakdown Data by Type
7.3 Europe Pneumococcal Vaccine Breakdown Data by Application
7.4 Europe Pneumococcal Vaccine Breakdown Data by Countries
7.4.1 Europe Pneumococcal Vaccine Sales by Countries
7.4.2 Europe Pneumococcal Vaccine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Pneumococcal Vaccine Breakdown Data by Company
8.2 Asia Pacific Pneumococcal Vaccine Breakdown Data by Type
8.3 Asia Pacific Pneumococcal Vaccine Breakdown Data by Application
8.4 Asia Pacific Pneumococcal Vaccine Breakdown Data by Regions
8.4.1 Asia Pacific Pneumococcal Vaccine Sales by Regions
8.4.2 Asia Pacific Pneumococcal Vaccine Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Pneumococcal Vaccine Breakdown Data by Company
9.2 Latin America Pneumococcal Vaccine Breakdown Data by Type
9.3 Latin America Pneumococcal Vaccine Breakdown Data by Application
9.4 Latin America Pneumococcal Vaccine Breakdown Data by Countries
9.4.1 Latin America Pneumococcal Vaccine Sales by Countries
9.4.2 Latin America Pneumococcal Vaccine Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Pneumococcal Vaccine Breakdown Data by Type
10.2 Middle East and Africa Pneumococcal Vaccine Breakdown Data by Application
10.3 Middle East and Africa Pneumococcal Vaccine Breakdown Data by Countries
10.3.1 Middle East and Africa Pneumococcal Vaccine Sales by Countries
10.3.2 Middle East and Africa Pneumococcal Vaccine Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Pfizer Pneumococcal Vaccine Products and Services
11.1.5 Pfizer SWOT Analysis
11.1.6 Pfizer Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Business Overview and Total Revenue (2019 VS 2018)
11.2.3 GSK Pneumococcal Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 GSK Pneumococcal Vaccine Products and Services
11.2.5 GSK SWOT Analysis
11.2.6 GSK Recent Developments
11.3 MSD
11.3.1 MSD Corporation Information
11.3.2 MSD Business Overview and Total Revenue (2019 VS 2018)
11.3.3 MSD Pneumococcal Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 MSD Pneumococcal Vaccine Products and Services
11.3.5 MSD SWOT Analysis
11.3.6 MSD Recent Developments
11.4 Sanofipasteur
11.4.1 Sanofipasteur Corporation Information
11.4.2 Sanofipasteur Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Sanofipasteur Pneumococcal Vaccine Products and Services
11.4.5 Sanofipasteur SWOT Analysis
11.4.6 Sanofipasteur Recent Developments
11.5 CDIBP
11.5.1 CDIBP Corporation Information
11.5.2 CDIBP Business Overview and Total Revenue (2019 VS 2018)
11.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 CDIBP Pneumococcal Vaccine Products and Services
11.5.5 CDIBP SWOT Analysis
11.5.6 CDIBP Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Pneumococcal Vaccine Sales Channels
12.2.2 Pneumococcal Vaccine Distributors
12.3 Pneumococcal Vaccine Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Pneumococcal Vaccine Sales Forecast (2021-2026)
13.1.1 Global Pneumococcal Vaccine Sales Forecast by Regions (2021-2026)
13.1.2 Global Pneumococcal Vaccine Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Pneumococcal Vaccine Sales Forecast (2021-2026)
13.2.2 North America Pneumococcal Vaccine Revenue Forecast (2021-2026)
13.2.3 North America Pneumococcal Vaccine Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Pneumococcal Vaccine Sales Forecast (2021-2026)
13.3.2 Europe Pneumococcal Vaccine Revenue Forecast (2021-2026)
13.3.3 Europe Pneumococcal Vaccine Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Pneumococcal Vaccine Sales Forecast (2021-2026)
13.4.2 Asia Pacific Pneumococcal Vaccine Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Pneumococcal Vaccine Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Pneumococcal Vaccine Sales Forecast (2021-2026)
13.5.2 Latin America Pneumococcal Vaccine Revenue Forecast (2021-2026)
13.5.3 Latin America Pneumococcal Vaccine Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Pneumococcal Vaccine Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Pneumococcal Vaccine Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Pneumococcal Vaccine Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Pfizer、GSK、MSD、Sanofipasteur、CDIBP

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 肺炎球菌ワクチンの世界市場2020-2026:PPSV 23、PCV 7/13、PCV 10(Global Pneumococcal Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。